Assessment of Psychopathology and Quality of Life in Children and Adolescents With Migraine

dc.contributor.authorOztop, Didem Behice
dc.contributor.authorTasdelen, Bedia Ince
dc.contributor.authorPoyrazogLu, Hatice Gamze
dc.contributor.authorOzsoy, Saliha
dc.contributor.authorYilmaz, Rabia
dc.contributor.authorSahin, Nilfer
dc.contributor.authorBozkurt, Selma
dc.date.accessioned2026-08-12T17:32:52Z
dc.date.issued2016
dc.departmentFırat Üniversitesi
dc.description.abstractAim: The aims of this study were to investigate comorbid psychiatric disorders and to identify anxiety and depression levels and quality of life in children and adolescents with migraine; and to assess their relationship with migraine. Method: 35 patients aged 9-16 years were followed in our neurology clinic and their parents were included into the study. 35 age- and sex-matched patients were employed as the control group. In the subjects included, psychiatric disorders were assessed by using the Schedule for Affective Disorders and Schizophrenia for School Age Children-Present and Lifetime Version. All children and adolescents were assessed by using the Children's Depression Inventory, the State-Trait Anxiety Inventory and the Pediatric Quality of Life Inventory. In addition, the Pediatric Migraine Disability Assessment Tool and visual analog scale were used to identify the degree of disability and pain severity in patients with migraine. Findings: In the psychiatric assessment of children and adolescents with migraine, it was found that a psychiatric diagnosis was made in 40% of patients; and depression scale scores were significantly higher than those of controls. Quality of life was found to be poorer in patients with migraine compared to controls. It was found that quality of life was negatively correlated with pain severity and degree of disability; while it was positively correlated with depression scores. Discussion: In children and adolescents with migraine, treatment of psychiatric disorders in addition to migraine therapy can facilitate migraine management and may decrease the need for prophylactic therapy.
dc.identifier.doi10.1177/0883073815623635
dc.identifier.endpage842
dc.identifier.issn0883-0738
dc.identifier.issn1708-8283
dc.identifier.issue7
dc.identifier.orcid0000-0003-2757-9641
dc.identifier.orcid0000-0002-6733-4836
dc.identifier.pmid26759448
dc.identifier.scopus2-s2.0-84969270814
dc.identifier.scopusqualityQ1
dc.identifier.startpage837
dc.identifier.urihttps://doi.org/10.1177/0883073815623635
dc.identifier.urihttps://hdl.handle.net/11508/56803
dc.identifier.volume31
dc.identifier.wosWOS:000376264800004
dc.identifier.wosqualityQ2
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherSage Publications Inc
dc.relation.ispartofJournal of Child Neurology
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20260511
dc.subjectmigraine
dc.subjectpsychopathology
dc.subjectquality of life
dc.subjectchild
dc.subjectadolescent
dc.titleAssessment of Psychopathology and Quality of Life in Children and Adolescents With Migraine
dc.typeArticle

Dosyalar